Extended inpatient monitoring in the transition from intravenous steroids to oral corticosteroid therapy in acute severe ulcerative colitis may be unnecessarily prolonging hospital stays, according to a new study from DDW 2024.
Patients with ASUC, which occurs in approximately 20% to 30% of UC patients, typically receive IV corticosteroids as initial therapy to achieve rapid control of inflammation (J Clin Med 2019;8[12]:2169), with guidelines suggesting that once clinical improvement is